Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Desiderata for computable representations of electronic health records-driven phenotype algorithms
Mo, Huan , Thompson, William K. , Rasmussen, Luke V. , Pacheco, Jennifer A. , Jiang, Guoqian , Kiefer, Richard C. , Zhu, Qian , Xu, Jie , Montague, Enid , Mentch, Frank , Ni, Yizhao , Wehbe, Firas , Peissig, Peggy , Tromp, Gerard , Larson, Eric B. , Pathak, Jyotishman , Denny, Joshua C. , Speltz, Peter, Jarvik, Gail P. , Bejan, Cosmin A, Borthwick, Kenneth M., Kitchner, Terrie, Roden, Dan M. , Bejan, Cosmin A. , Kiefer, Richard, Carrell, David , Lingren, Todd , Chute, Christopher G. , Kho, Abel , Bejan, Cosmin A, Williams, Marc S , Roden, Dan M. , Harris, Paul A. , Denny, Joshua C , Jarvik, Gail P , Rasmussen, Luke V , Pacheco, Jennifer A

Journal of the American Medical Informatics Association | September 6, 2015 | Volume: 22 | Issue: 6 | Pages: 1220-1230

10.1093/jamia/ocv112 | PMID 26342218 Get It

AbstractBackground Electronic health records (EHRs) are increasingly used for clinical and translational research through the creation of phenotype algorithms. Currently, phenotype algorithms are most commonly represented as noncomputable descriptive documents and knowledge artifacts that detail the protocols for querying diagnoses, symptoms, procedures, medications, and/or text-driven medical concepts, and are primarily meant for human comprehension. We present desiderata for developing a computable phenotype representation model (PheRM).Methods A team of clinicians and informaticians reviewed common features for multisite phenotype algorithms published in PheKB.org and existing phenotype representation platforms. We also evaluated well-known diagnostic criteria and clinical decision-making guidelines to encompass a broader category of algorithms.Results We propose 10 desired characteristics for a flexible, computable PheRM: (1) structure clinical data into queryable forms; (2) recommend use of a common data model, but also support customization for the variability and availability of EHR data among sites; (3) support both human-readable and computable representations of phenotype algorithms; (4) implement set operations and relational algebra for modeling phenotype algorithms; (5) represent phenotype criteria with structured rules; (6) support defining temporal relations between events; (7) use standardized terminologies and ontologies, and facilitate reuse of value sets; (8) define representations for text searching and natural language processing; (9) provide interfaces for external software algorithms; and (10) maintain backward compatibility.Conclusion A computable PheRM is needed for true phenotype portability and reliability across different EHR products and healthcare systems. These desiderata are a guide to inform the establishment and evolution of EHR phenotype algorithm authoring platforms and languages.
Prediction of Cardiac and Noncardiac Mortality After Percutaneous Coronary Intervention
Spoon, Daniel B., Lennon, Ryan J. , Psaltis, Peter J. , Prasad, Abhiram , Holmes, David R. , Rihal, Charanjit S. , Ting, Henry H. , Gulati, Rajiv , Lerman, Amir , Rihal, Charanjit S. , Gersh, Bernard J. , Singh, Mandeep , Prasad, Abhiram

Circulation: Cardiovascular Interventions | September 5, 2015 | Volume: 8 | Issue: 9 | Pages: No page available

10.1161/circinterventions.114.002121 | PMID 26341735 Get It

Background— Current risk models for predicting long-term mortality after percutaneous coronary intervention are restricted to all-cause mortality. We sought to develop novel risk models for the prediction of cardiac and noncardiac mortality after percutaneous coronary intervention. Methods and Results— We retrospectively evaluated patients who underwent index percutaneous coronary intervention at Mayo Clinic from 2003 to 2008. Long-term deaths were ascertained through scheduled prospective surveillance. Cause of death was determined via telephone interviews, medical records, and autopsy reports. Fine and Gray extension of Cox proportional hazards models was used to model cause-specific cumulative incidence. Candidate variables and interactions were chosen a priori, without variable selection methods. Resulting models were mapped to an integer-based risk score. The study comprised 6636 patients followed up over a median of 62 months (25th, 75th percentiles: 45, 77 months). There were 1488 deaths, 518 (35%) cardiac, 938 (63%) noncardiac, and 32 (2%) unknown. The 5-year predicted cardiac mortality ranged from 0.6% to 97%, with a corrected c -statistic of 0.82. Risk factors for cardiac death included age, body mass index, ejection fraction, and history of congestive heart failure. The integer score for noncardiac death included age, medicine index, body mass index, current smoker, noncardiac Charlson index and cardiac Charlson index, and accommodated significant age-based interactions for smoking and the 2 Charlson indices. Predicted noncardiac mortality at 5 years ranged from 0.2% to 81%, with a corrected c -statistic of 0.77. Conclusions— We report novel risk models to predict cardiac and noncardiac long-term mortality after percutaneous coronary intervention.
Response to the Letter by Pauwels, et al
Hawkes, Colin P. , Schnellbacher, Sarah, Singh, Rajat , Levine, Michael A. , Levine, M A

The Journal of Clinical Endocrinology & Metabolism | September 4, 2015 | Volume: 100 | Issue: 9 | Pages: L84-L85

10.1210/jc.2015-3007 | PMID 26339746 Get It

Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder
Erol, Almıla , Winham, Stacey J. , Frye, Mark A. , Prieto, Miguel L. , Cuéllar‐Barboza, Alfredo B. , Geske, Jennifer R. , Mori, Nicole, Prieto, Miguel L , Geske, Jennifer, Bobo, William V. , McElroy, Susan L. , Fuentes, Manuel Enrique , Biernacka, Joanna M. , Winham, Stacey J , Cuellar-Barboza, Alfredo , Geske, Jennifer

Bipolar Disorders | September 4, 2015 | Volume: 17 | Issue: 6 | Pages: 670-676

10.1111/bdi.12329 | PMID 26529373 Get It

ObjectivesTo examine the independent effects of sex on the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I disorder (BP‐I) or bipolar II disorder (BP‐II).MethodsWe analyzed data from the first 1,225 patients enrolled in the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder. Demographic and clinical variables were ascertained using standardized questionnaires; height and weight were assessed to determine body mass index (BMI). Rates of rapid cycling, cycle acceleration, and increased severity of mood episodes over time were compared between women and men overall and within subgroups defined by bipolar disorder subtype (BP‐I or BP‐II). Multiple logistic regression analysis was used to assess the independent effect of sex on the risk of these indicators of adverse illness course.ResultsWomen had significantly higher rates of rapid cycling than men. Overall rates of rapid cycling were higher in patients with BP‐II than BP‐I; and sex differences in the rate of rapid cycling were more pronounced in patients with BP‐II than BP‐I, although the power to detect statistically significant differences was reduced due to the lower sample size of subjects with BP‐II. Female sex was a significant predictor of rapid cycling, cycle acceleration, and increased severity of mood episodes over time after adjusting for age, bipolar disorder subtype, BMI, having any comorbid psychiatric disorder, and current antidepressant use.ConclusionsFemale sex was associated with significantly higher risk of rapid cycling, cycle acceleration, and increased severity of mood episodes over time in a sample of 1,225 patients with bipolar disorders.
Association of brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism with early‐onset bipolar disorder
Nassan, Malik , Croarkin, Paul E. , Veldić, Marin , Joshi, Paramjit T. , Post, Robert M, Walkup, John T. , Cercy, Kelly, Geske, Jennifer R. , Wagner, Karen Dineen, Cuéllar‐Barboza, Alfredo B. , Casuto, Leah, Lavebratt, Catharina , Schalling, Martin , Jensen, Peter S. , Frye, Mark A. , Luby, Joan L. , McElroy, Susan L. , Post, Robert M, Biernacka, Joanna M. , Cuellar-Barboza, Alfredo , Veldic, Marin , Croarkin, Paul E , Lavebratt, Catharina , Geske, Jennifer

Bipolar Disorders | September 4, 2015 | Volume: 17 | Issue: 6 | Pages: 645-652

10.1111/bdi.12323 | PMID 26528762 Get It

ObjectivesBrain‐derived neurotrophic factor (BDNF) Val66Met (rs6265) functional polymorphism has been implicated in early‐onset bipolar disorder. However, results of studies are inconsistent. We aimed to further explore this association.MethodsDNA samples from the Treatment of Early Age Mania (TEAM) and Mayo Clinic Bipolar Disorder Biobank were investigated for association of rs6265 with early‐onset bipolar disorder. Bipolar cases were classified as early onset if the first manic or depressive episode occurred at age ≤19 years (versus adult‐onset cases at age >19 years). After quality control, 69 TEAM early‐onset bipolar disorder cases, 725 Mayo Clinic bipolar disorder cases (including 189 early‐onset cases), and 764 controls were included in the analysis of association, assessed with logistic regression assuming log‐additive allele effects.ResultsComparison of TEAM cases with controls suggested association of early‐onset bipolar disorder with the rs6265 minor allele [odds ratio (OR) = 1.55, p = 0.04]. Although comparison of early‐onset adult bipolar disorder cases from the Mayo Clinic versus controls was not statistically significant, the OR estimate indicated the same direction of effect (OR = 1.21, p = 0.19). When the early‐onset TEAM and Mayo Clinic early‐onset adult groups were combined and compared with the control group, the association of the minor allele rs6265 was statistically significant (OR = 1.30, p = 0.04).ConclusionsThese preliminary analyses of a relatively small sample with early‐onset bipolar disorder are suggestive that functional variation in BDNF is implicated in bipolar disorder risk and may have a more significant role in early‐onset expression of the disorder.
Body-Related Emotions in Posttraumatic Stress Disorder Following Childhood Sexual Abuse
Dyer, Anne , Feldmann, Robert , Borgmann, Elisabeth

Journal of Child Sexual Abuse | September 4, 2015 | Volume: 24 | Issue: 6 | Pages: 627-640

10.1080/10538712.2015.1057666 | PMID 26340071 Get It

LRRK2 and ubiquitination: implications for kinase inhibitor therapy
Melrose, Heather L.

Biochemical Journal | September 4, 2015 | Volume: 470 | Issue: 3 | Pages: e21-e24

10.1042/bj20150785 | PMID 26341487 Get It

Pathogenic mutations and risk variants in LRRK2 (leucine-rich repeat kinase 2) represent the most common genetic cause of familial and sporadic PD (Parkinson's disease). LRRK2 protein is widely expressed throughout the brain and the periphery. Structurally, LRRK2 contains several functional domains, including a dual enzymatic core consisting of a kinase and GTPase domain. Disease-linked variants are found in both these enzymatic domains as well as in the COR [C-terminal of ROC (Ras of complex proteins)] and WD40 protein–protein binding domain. The kinase domain is widely believed to be linked to toxicity, and thus the thrust of pharmaceutical effort has focused on developing LRRK2 kinase inhibitors. However, recent data have suggested that inhibition of LRRK2 activity results in reduced LRRK2 levels and peripheral side effects, which are similar to those observed in homozygous LRRK2-knockout and LRRK2 kinase-dead rodent models. In a recent issue of the Biochemical Journal, a study led by Nichols reveals that dephosphorylation of LRRK2 cellular phosphorylation sites (Ser910/Ser935/Ser955/Ser973) triggers its ubiquitination and subsequent degradation and thus may account for the loss of function phenotypes observed in peripheral tissues in LRRK2-knockout/kinase-dead or inhibitor-treated rodents and primates. Albeit negative from a kinase inhibitor standpoint, the data open new avenues for LRRK2 biology and therapeutic approaches to counteract LRRK2 toxicity.
What's up #DOC? The role of social media in diabetes management
O’Keeffe, Derek T. , Montori, Víctor M. , Montori, Victor M

Diabetic Medicine | September 4, 2015 | Volume: 33 | Issue: 6 | Pages: 853-854

10.1111/dme.12955 | PMID 26337176 Get It

Inhibition of Autophagy Increases 2-Methoxyestradiol-Induced Cytotoxicity in SW1353 Chondrosarcoma Cells
Reumann, Stephan, Shogren, Kristen L., Yaszemski, Michael J. , Maran, Avudaiappan

Journal of Cellular Biochemistry | September 3, 2015 | Volume: 117 | Issue: 3 | Pages: 751-759

10.1002/jcb.25360 | PMID 26335692 Get It